Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Ascletis Pharma Inc (1672 HK)
Watchlist
67
Analysis
Health Care
•
China
Ascletis Pharma Inc. operates as a biotechnology company. The Company develops and discovers anti-viral drugs to address unmet medical needs in anti-viral, cancer, and fatty liver disease. Ascletis Pharma offers its services worldwide.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
02 Jul 2024 08:06
Voluntary Announcement - Proposed Share Repurchase Under The Repurchase Mandate
Attachment
Exchange Announcement •
11 Jun 2024 08:02
Voluntary Announcement - Gannex Announces Poster Presentation Describing Positive Interim 12-Week Results From Ongoing 52-Week Phase Ii Clinical Trial Of Once-Daily Asc41 In Patients With Biopsy-Confirmed Mash At Easl Congress 2024
Attachment
Exchange Announcement •
23 May 2024 17:30
Poll Results Of Annual General Meeting Held On May 23, 2024
Attachment
Exchange Announcement •
26 Apr 2024 16:55
Form Of Proxy For The 2024 Annual General Meeting
Attachment
Exchange Announcement •
26 Apr 2024 16:53
Notice Of 2024 Annual General Meeting
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.1
x